Search Results - "Moffa, Simona"
-
1
Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives
Published in Cardiovascular diabetology (28-02-2019)“…Sotagliflozin is a dual sodium-glucose co-transporter-2 and 1 (SGLT2/1) inhibitor for the treatment of both type 1 (T1D) and type 2 diabetes (T2D)…”
Get full text
Journal Article -
2
Potential cause-effect relationship between insulin autoimmune syndrome and alpha lipoic acid: Two case reports
Published in Nutrition (Burbank, Los Angeles County, Calif.) (01-01-2019)“…•We here report two new cases of insulin autoimmune syndrome (IAS) triggered by alpha lipoic acid in two Caucasian women.•This new cases are associated with…”
Get full text
Journal Article -
3
Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features
Published in Nutrients (21-12-2022)“…Alpha-lipoic acid (ALA) is a natural compound with antioxidant and pro-oxidant properties which has effects on the regulation of insulin sensitivity and…”
Get full text
Journal Article -
4
Physical Activity and Type 2 Diabetes: In Search of a Personalized Approach to Improving β-Cell Function
Published in Nutrients (28-09-2023)“…Type 2 diabetes mellitus (T2DM) is one of the most widespread diseases worldwide. Lifestyle interventions, including diet and physical activity (PA), are…”
Get full text
Journal Article -
5
The Interplay between Immune System and Microbiota in Diabetes
Published in Mediators of inflammation (2019)“…Diabetes is not a single and homogeneous disease, but a cluster of metabolic diseases characterized by the common feature of hyperglycemia. The pathogenesis of…”
Get full text
Journal Article -
6
A novel low-density lipoprotein receptor variant in a Ukrainian patient: a case report and overview of the disease-causing low-density lipoprotein receptor variants associated to familial hypercholesterolemia
Published in Molecular biology reports (01-02-2022)“…Background Familial hypercholesterolemia (FH) is characterized by high low-density lipoprotein-cholesterol levels and it is primarily caused by…”
Get full text
Journal Article -
7
Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: evidence to date
Published in Drug design, development and therapy (01-01-2017)“…Sodium-glucose cotransporter 2 (SGLT2) inhibitors are the latest therapeutic strategy in the treatment of type 2 diabetes mellitus (T2DM). Using an…”
Get full text
Journal Article -
8
Effects of PCSK9 inhibition on glucose metabolism and β-cell function in humans: a pilot study
Published in Frontiers in endocrinology (Lausanne) (31-05-2023)“…Anti-PCSK9 monoclonal antibodies are effective in reducing LDL-C and cardiovascular events by neutralizing circulating PCSK9. PCSK9, however, is also expressed…”
Get full text
Journal Article -
9
Bile Modulates Secretion of Incretins and Insulin: A Study of Human Extrahepatic Cholestasis
Published in The journal of clinical endocrinology and metabolism (01-07-2019)“…Abstract Objective Changes in bile flow after bariatric surgery may beneficially modulate secretion of insulin and incretins, leading to diabetes remission…”
Get full text
Journal Article -
10
108-OR: Insulin Resistance Is Associated with Alterations in the Dynamics of Incretin Secretion
Published in Diabetes (New York, N.Y.) (01-06-2024)“…GIP and GLP-1 exert a fundamental role in glucose homeostasis, but it is still debated if modifications in GIP and GLP-1 secretion can affect the metabolic…”
Get full text
Journal Article -
11
Why do some glucose-lowering agents improve non-alcoholic fatty liver disease whereas others do not? A narrative review in search of a unifying hypothesis
Published in Diabetes/metabolism research and reviews (01-10-2023)“…Non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2D) are metabolic disorders connected by common pathophysiological mechanisms. Since insulin…”
Get full text
Journal Article -
12
1559-P: Heterogeneity of Trajectories of Metabolic Parameters after 50% Beta-Cell Mass Loss by Pancreatectomy
Published in Diabetes (New York, N.Y.) (14-06-2024)“…Temporal trajectories of metabolic parameters in the onset of dysglycemia are heterogeneous. We aimed to characterize the temporal trajectories of metabolic…”
Get full text
Journal Article -
13
1535-P: Type 2 Diabetes Remission after Roux-en-Y Gastric Bypass Is Related to a Reduction of Pancreatic Noradrenergic Innervation and Beta-Cell Redifferentiation
Published in Diabetes (New York, N.Y.) (01-06-2024)“…Background: β cell dedifferentiation has been identified as the process responsible for the functional "disappearance" of β cells from the islets of diabetic…”
Get full text
Journal Article -
14
Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional β cells in predicting diabetes
Published in The Journal of clinical investigation (15-06-2021)“…BACKGROUND. The appearance of hyperglycemia is due to insulin resistance, functional deficits in the secretion of insulin, and a reduction of ß cell mass…”
Get full text
Journal Article -
15
First-phase insulin secretion: can its evaluation direct therapeutic approaches?
Published in Trends in endocrinology and metabolism (01-04-2023)“…β Cells can adapt to pathological metabolic conditions by implementing plasticity mechanisms to increase their mass and enhance insulin secretion, thus…”
Get full text
Journal Article -
16
Reduced incretin effect precedes diabetes development following duodenopancreatectomy in individuals without diabetes
Published in The Journal of clinical investigation (15-04-2024)Get full text
Journal Article -
17
4772 DOUBLE FILTRATION PLASMAPHERESIS DURING HETEROLOGOUS FERTILIZATION PREGNANCY FOR THE TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Published in Nephrology, dialysis, transplantation (14-06-2023)“…Abstract Background and Aims Pregnancy in women affected by familial hypercholesterolemia is rare. Estrogen and progesterone fluctuations, featuring pregnancy,…”
Get full text
Journal Article -
18
1068-P: Reassessing Insulin Therapy In Diabetes of the Exocrine Pancreas-A Pilot Study
Published in Diabetes (New York, N.Y.) (01-06-2024)“…Cohort studies have demonstrated that subjects with diabetes of the exocrine pancreas (DEP) are mostly treated with basal bolus insulin. To reassess insulin…”
Get full text
Journal Article -
19
1754-P: Reduced Incretin Effect Predicts Diabetes Appearance in a Cohort of Nondiabetic Subjects after Acute Beta-Cell Mass Reduction
Published in Diabetes (New York, N.Y.) (20-06-2023)“…In type 2 diabetes incretin effect (IE) is reduced but still contributes to 20-35% of insulin response to oral glucose. One reason is the impairment of GIP and…”
Get full text
Journal Article -
20
2110-P: Correlation between Ex Vivo Islet Proteomic Analysis and In Vivo Secretory Function in Humans
Published in Diabetes (New York, N.Y.) (01-06-2020)“…Insulin resistance and β-cell dysfunction are the main actors in the pathogenesis of type 2 diabetes mellitus, causing both quantitative and qualitative loss…”
Get full text
Journal Article